WHO ICTRP trial
Determining the role of Von Willebrand factor and ADAMTS13 in the adhesion of…
NL-OMON32743 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON32743 |
|---|---|
| Public title | Determining the role of Von Willebrand factor and ADAMTS13 in the adhesion of sickled erythrocytes to endothelial cells |
| Scientific title | Determining the role of Von Willebrand factor and ADAMTS13 in the adhesion of sickled erythrocytes to endothelial cells - The role of VWF and ADAMTS13 in vascular occlusion in sickle cell disease |
| Primary sponsor | Academisch Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational non invasive |
| Countries | The Netherlands |
| Conditions | hereditary anemia sickle cell disease;10038158;10027664;hereditary anemia;sickle cell disease |
| Interventions | ;children;sickle cell disease;silent infarcts;von willebrand factor |
| Registration date | Nov 26, 2009 |
| Target size | 10 |
| Secondary IDs | NL29705.018.09 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: